Procurement of Follicular B Cell Lymphoma Cells for the Purpose of Possible Use in Future Clinical Trials

计划入组 40 人 · 首次发布于 2007 年 6 月 18 日

Duvelisib Exposure to Enhance Immune Profiles of T Cells in Patients With Recurrent or Refractory Diffuse Large B-Cell Lymphoma, DEEP T CELLS Study

计划入组 4 人 · 首次发布于 2021 年 5 月 18 日

Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19

计划入组 50 人 · 首次发布于 2007 年 4 月 27 日

CFR64 T-cells (Infusion, B-cell lymphoma)

deubiquitinating enzyme inhibitor (B-Cell lymphoma)

B Cell lymphoma vaccine(Genitope Corp.)

STEM CELLS ARABIA

Jordan

Personalized Stem Cells, Inc.

United States

KLSMC Stem Cells, Inc.

Chimeric Molecule Induces Self-Destruction in Lymphoma Cells by Linking BCL6 and CDK9

Tazemetostat-Pinometostat Combination Shows Promise for B-Cell Lymphoma Treatment Resistance

Long-Term JULIET Trial Data Shows CAR-T Therapy Delivers Durable Survival in Relapsed B-Cell Lymphoma